Fig. S6.
Induction of U-ISGF3 after treatment of IFN-β and IFN-λ1 in PHHs, differentiated HepaRG cells, and HepG2 cells. PHHs, differentiated HepaRG cells, and HepG2 cells were treated with 1 ng/mL IFN-β or 100 ng/mL IFN-λ1 and harvested at the indicated time points. Immunoblotting of STAT1, PY-STAT1, STAT2, PY-STAT2, and IRF9 was performed.